Shares of Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) traded down 10.2% during trading on Monday . The stock traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares traded hands during trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).
Wall Street Analysts Forecast Growth
A number of research firms recently commented on ONT. Berenberg Bank reiterated a "buy" rating and set a GBX 282 ($3.54) price target on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 190 ($2.38) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. restated an "overweight" rating on shares of Oxford Nanopore Technologies in a report on Friday, December 6th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of GBX 235.50 ($2.95).
Get Our Latest Analysis on ONT
Oxford Nanopore Technologies Stock Performance
The business's 50 day moving average is GBX 142.50 and its two-hundred day moving average is GBX 129.78. The company has a market cap of £1.21 billion, a PE ratio of -642.50 and a beta of 0.80. The company has a current ratio of 4.45, a quick ratio of 6.01 and a debt-to-equity ratio of 8.07.
Insider Activity at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of Oxford Nanopore Technologies stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,548,791.30). In the last 90 days, insiders have acquired 310 shares of company stock valued at $45,010. 32.62% of the stock is owned by company insiders.
About Oxford Nanopore Technologies
(
Get Free Report)
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oxford Nanopore Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.
While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.